Related Experiment Videos

Decreased expression of Bcl-x protein during hepatocarcinogenesis induced exogenously and endogenously in rats

Y Hatanaka1, D Nakae, M Mutai

  • 1Division of Life Science, Graduate School of Science and Technology, Kobe University, Nada-ku, Kobe, Hyogo 657-8501, Japan.

Insights

Decreased Bcl-x protein expression in rat liver is linked to preneoplastic lesions and hepatocellular carcinoma development. This reduction may indicate advanced disease and potential cancer progression in both induced and diet-related liver cancer models.

Area of Science:

  • Hepatocarcinogenesis research
  • Molecular oncology
  • Apoptosis regulation

Background:

  • Dysregulation of apoptosis is crucial in cancer development.
  • Bcl-x, a Bcl-2 family member, regulates apoptosis.
  • Altered Bcl-x expression is implicated in carcinogenesis.

Purpose of the Study:

  • To investigate the role of Bcl-x protein expression changes in rat hepatocarcinogenesis.
  • To assess Bcl-x alterations in both chemically induced and diet-induced liver cancer models.

Main Methods:

  • Exogenous models: Rats treated with diethylnitrosamine (DEN) and phenobarbital.
  • Endogenous model: Rats fed a choline-deficient, L-amino acid-defined diet.
  • Analysis of glutathione S-transferase (GST-P)-positive lesions, Bcl-x expression, apoptosis, and cell proliferation.

Main Results:

  • Decreased Bcl-x protein expression was observed in preneoplastic lesions (GST-P-positive) and hepatocellular carcinomas.
  • The incidence of decreased Bcl-x increased with lesion size in exogenous models.
  • Reduced Bcl-x correlated with enhanced apoptosis and cell proliferation in larger lesions.
  • Hepatocellular carcinomas showed decreased Bcl-x expression in both exogenous and endogenous models.

Conclusions:

  • A decrease in Bcl-x protein may serve as an indicator of advanced preneoplastic lesions.
  • Reduced Bcl-x expression is associated with the progression potential to carcinoma in rat hepatocarcinogenesis.
  • Findings highlight Bcl-x as a potential biomarker in liver cancer development.

Related Concept Videos